Researchers from the University of Texas at Dallas have developed a sensor to detect and quantify glucose levels in sweat for at-home monitoring of patients with diabetes, according to a study published in Sensors and Actuators B: Chemical. Get the full story at our sister site, Medical Design & Outsourcing.
Hong Kong researchers use smartphone tech to screen thousands for atrial fibrillation
Researchers screened more than 13,000 Hong Kong citizens for atrial fibrillation using a smartphone-based, wireless, single-lead ECG, according to a study published yesterday in Heart. Afib can increase a person’s risk of heart failure and ischemic stroke, which can result in permanent neurological disability. Oral anticoagulation therapy can reduce the risk of ischemic stroke, but there is […]
Bayer eyes $1B sale of medical skin cream business
(Reuters) — Bayer (ETR:BAYN) has short-listed India’s Lupin (NSE:LUPIN) and investor BC Partners as prospective buyers of medical skin cream assets in a potentially €1 billion ($1.1 billion) deal, several people familiar with the sale told Reuters. Germany’s Bayer has for more than 2 years sought to narrow the focus of its healthcare division and its planned $66 billion Monsanto […]
Codiak BioSciences lures Alnylam vet Sorensen to lead clinical program
Codiak BioSciences said today that it has named former Alnylam Pharmaceuticals (NSDQ:ALNY) executive Dr. Benny Sorensen as vice president and head of clinical development. Sorensen was Alnylam’s senior director of clinical research, leading the preclinical, clinical, regulatory and commercial strategies for hematology products. He also worked for Baxter (NYSE:BAX), advancing hematology therapies through Phase III pivotal development. Get the […]
Ocular Therapeutix inks $315 deal with Regeneron
Ocular Therapeutix (NSDQ:OCUL) said today that it landed a licensing deal with Regeneron (NSDQ:REGN) to develop a sustained-release version of Regeneron’s aflibercept (Eylea), a therapy for wet age-related macular degeneration. The deal will cost Regeneron $10 million up front, and in total could cost the Tarrytown, N.Y.-based biotech $315 million if regulatory and commercialization milestones are met. Get the […]
JDRF backs Canadian islet transplant trial for Type I diabetes
The Juvenile Diabetes Research Foundation said today it is backing a 3 year study conducted by researchers at the University of Toronto to improve islet transplantation and make the procedure available for patients with type 1 diabetes. The research group was awarded $845,135 ($1.1 million Canadian) to evaluate if transplanting islet cells under the skin […]
Real-time MRI in stem cell therapy for Parkinson’s
Researchers have observed that using intraoperative real-time MRI to guide induced pluripotent stem cell-derived neurons into the brains of non-human primates modeled with Parkinson’s disease yields better visualization and increased cell survival. The study, which will be published in the American Society for Neural Therapy and Repair issue of Cell Transplantation, was conducted at the Wisconsin National Primate […]
Tunable hydrogel helps predict tissue response to chemo
Researchers from the Wyss Institute have developed a hydrogel microenvironment to evaluate how physical properties like stiffness of the extracellular matrix impacts the efficacy of chemotherapy. “To have success with chemotherapy and other drug therapies, we will likely need to screen their effectiveness against cells living in various environments, and not just assume that cells […]
Bioprinted 3D renal architecture recapitulates kidney function
Researchers from the Wyss Institute for Biologically Inspired Engineering at Harvard University have bioprinted a functional 3D renal architecture with living human epithelial cells. Previously, the team bioprinted tissue constructs made of living cells alongside a vascular network in an extracellular matrix. These constructs are functional in vitro for more than a month. Get the full […]
SEC launches probe, investors file suit against Mylan over EpiPen pricing
Despite a $465 million settlement with the U.S. Justice Dept., Mylan (NSDQ:MYL) is still under fire for misclassifying its EpiPen auto-injector with the Centers for Medicare & Medicaid Services. Last week, the Securities & Exchange Commission’s enforcement division launched an investigation into the Canonsburg, Pa.-based company’s history with CMS; yesterday investors filed a purported class […]
Novocure enrolls 1st patient in phase III brain metastases trial
Novocure (NSDQ:NVCR) said that the 1st patient has been enrolled in a Phase III pivotal trial of its tumor-treating field technology in combination with radiosurgery to treat brain metastases from non-small-cell lung cancer. The St. Helier, N.J.-based company’s tumor treating fields (TTFields) are low-intensity, intermediate-frequency, alternating electric fields designed to disrupt cell division within cancer cells. Novocure’s commercial product, Optune, […]